icon-folder.gif   Conference Reports for NATAP  
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
Validation of Fractional Synthesis Rate of Plasma Lumican as a Noninvasive Marker of Fibrogenesis in Patients With Nonalcoholic Steatohepatitis
  Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Rohit Loomba,1 Eric J. Lawitz,2 Edward Gane,3 Peter J. Ruane,4 Jie Zhang,5 Lulu Wang,5 Guang Chen,5 Jen-Chieh Chuang,5 Bryan J. McColgan,5 Chuhan Chung,5 G. Mani Subramanian,5 Robert P. Myers,5 Michael S. Middleton,1 Mazen Noureddin,6 Stephen A. Harrison,7 Kelvin W. Li,8 Marc Hellerstein8
1UC San Diego, La Jolla, CA; 2Texas Liver Institute, UT Health San Antonio, TX; 3Auckland City Hospital, Auckland, New Zealand; 4Ruane Clinical Research Group, Inc., Los Angeles, CA; 5Gilead Sciences, Inc., Foster City, CA; 6Cedars-Sinai Medical Center, Los Angeles, CA; 7Pinnacle Research, San Antonio, TX; 8UC Berkeley, Berkeley, CA